Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: A5: The majority of people who become addicted to opioids started using opioids for pain. We've got to find alterna… https://t.co/9QqVF8Pl39
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: As we address the opioid crisis we must protect the needs of patients with chronic and acute pain. FDA is focused o… https://t.co/dApvDrJWRu
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: Honored to be designated the Chair of the Biodefense Steering Committee and thank @POTUS for his leadership in prioritizing th… QT @realDonaldTrump: Today, I took action to strengthen our Nation’s defenses against biological threats. For the first time in history,… https://t.co/rohX3hoIR3)
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA announced a broad public education campaign aimed at kids to warn them about the dangers of e-cigs; as we mount a comprehensive effort to combat what new data convincingly proves is an epidemic level rise in the use of these products by teens. https://t.co/s2Atn2HasK
SteveFDA (R-D.C.)
@SGottliebFDA
RT @Fahrenthold: When a fire broke out at a seniors’ home in DC today, Marines from a nearby barracks ran over to rescue residents. https:… QT @lmedsker: Marines from 8 and I running towards the fire raging in SE DC. https://t.co/4vSKsuyTGo)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FortuneMagazine: FDA unveils its latest weapon in fighting teen vaping epidemic: ads in high school bathrooms https://t.co/JCFkHmnprN
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: @WSJ: "Open Your App and Say ‘Ahh’ - Smartphones and better electronic health records have the potential to revolut… https://t.co/bvRZBEno2D
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: We support @US_FDA’s sustained efforts to address youth e-cigarette use. These products may offer an important oppo… https://t.co/mB5Bv0syIx
SteveFDA (R-D.C.)
@SGottliebFDA
@WSJ: "Open Your App and Say ‘Ahh’ - Smartphones and better electronic health records have the potential to revolutionize medicine." From FDA's @PaulHowardNYC and @SeanKhozin https://t.co/mlSECDbBdl
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA has completed review of all available data on the use of Nuplazid - no new or unexpected safety findings have b… https://t.co/6o8jHx4Cyw
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: New Director's Corner Podcast: Drug Shortages. Listen here: https://t.co/BNC19LmFNX. https://t.co/xszr41WdxY
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FoxBusiness: FDA Commissioner @SGottliebFDA on e-cigarettes: "We now have evidence that this has reached epidemic proportions." https://t.co/aLoghWrwkM
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: For those who have been tracking, #FDA has completed review of all available data on the use of Nuplazid - no new o… https://t.co/vgoiRfol5J
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: “The Real Cost” E-Cigarette Prevention Campaign aims to educate 10.7 million youth aged 12-17 who have used e-cigs… https://t.co/EflVf4wwIF
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FoxBusiness: FDA Commissioner @SGottliebFDA on the generic version of the Epi-Pen: "We've invested a lot of resources in trying… https://t.co/3A5mwPLYZf
SteveFDA (R-D.C.)
@SGottliebFDA
RT @dailybriefing: FDA Commissioner @SGottliebFDA talks vaping, opioids, and more. https://t.co/xOSsJhIFAl
SteveFDA (R-D.C.)
@SGottliebFDA
We're committed to policies that promote innovations that empower consumers to be more informed about their health; and to regulatory approaches that make it easier for traditional technology companies to bring medical functionality to their platforms: https://t.co/VRrbss5Xio
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FoxBusiness: FDA Commissioner @SGottliebFDA on the generic version of the Epi-Pen: "We've invested a lot of resources in trying… https://t.co/PkN1VDjxtE
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_ORA: FDA’s Special Agents/@TheJusticeDept: Massachusetts doctor sentenced for illegally sharing patient medical files an… https://t.co/wr3u5ZdYNm
SteveFDA (R-D.C.)
@SGottliebFDA
We're undertaking a comprehensive effort to address the structural woes that underpin or exacerbate drug shortages, especially as it relates to sterile parenteral drugs. We'll address regulatory and reimbursement issues. This workshop is part of that plan: https://t.co/qykuRpQqPZ